PARVOKAN

Country: Italy

Language: English

Source: HMA (Heads of Medicines Agencies)

Buy It Now

Active ingredient:

derszy's disease virus 2.5 log10 CCID50, muscovy duck parvovirus inactivated 1.5 log10 SN.U

Available from:

Merial

ATC code:

QI01BH01

Pharmaceutical form:

Live freeze-dried pellet for suspension for injection

Therapeutic group:

live goose parvovirus + inactivated duck parvovirus

Therapeutic area:

Other Birds

Authorization date:

2012-02-24

Summary of Product characteristics

                                 
 
 
 
_ _
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY OF PRODUCT CHARACTERISTICS
 
 
 
 
1. 
NAME OF THE VETERINARY MEDICINAL PRODUCT 
 
PARVOKAN 
 
 
2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Each 0.2-ml dose contains: 
ACTIVE SUBSTANCES: 
_Suspension_: 
Inactivated Muscovy duck parvovirus, GM strain,
at least ......................................................  1.5
log10 SN.U 
_Freeze-dried pellet_: 
Live attenuated Derzsy’s Disease virus, H strain,
at least.....................................................  2.5
log10 CCID50 
1 SN.U: q.s. to obtain a mean seroneutralizing antibody titre of
1 in the vaccinated animal
 
 
ADJUVANT(S): 
_Suspension_: 
Al
3+
 (as aluminium hydroxide) ............................................................................................................. 0.42
mg 
 
EXCIPIENT(S): 
_Suspension_: 
Thiomersal,
at most ...............................................................................................................................  20
µg 
 
For a full list of excipients, see section 6.1. 
 
 
3. 
PHARMACEUTICAL FORM 
 
Freeze-dried pellet and
suspension for suspension for injection. 
 
 
4. 
CLINICAL PARTICULARS 
 
4.1 
TARGET SPECIES 
 
Muscovy ducks. 
 
4.2 
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES 
 
In Muscovy ducklings: 
Active immunisation against Muscovy duck parvovirosis and
Derzsy’s Disease. 
The onset of immunity for both components was demonstrated
from the age of 14 days, and lasts all the period of 
maximal susceptibility of ducklings (i.e. 4 weeks of age). 
 
4.3 
CONTRAINDICATIONS 
 
None known. 
 
 
 
 
 
4.4 
SPECIAL WARNINGS 
 
None. 
 
4.5 
SPECIAL PRECAUTIONS FOR USE 
 
SPECIAL PRECAUTIONS FOR USE IN ANIMALS 
 
-  Vaccinate healthy animals only. 
-  Apply the usual aseptic procedures. 
-  Only
                                
                                Read the complete document
                                
                            

Search alerts related to this product

View documents history